Nisoldipine: A replacement therapy for nifedipine in the treatment of severe hypertension The use of nisoldipine (1020 mg b.i.d.) was evaluated as a replacement therapy for long-acting nifedipine (40120 mg/day) in 21 patients with severe hyperte... E Grossman,T Rosenthal - 《Clinical Car...
TREATMENT OF SEVERE HYPERTENSION IN THE EMERGENCY ROOM: USEFULNESS OF A NEW STEPPED‐CARE APPROACH: P2.2An abstract is unavailable.doi:10.1097/00004872-200006001-00293Kotliar, C.Ramos, F.Baglivo, H.Agranatti, D.De Pietro, P.Mautner, B.
Treatment of severe hypertension with atenolol and betaxolol with once-daily regimens: Hemodynamic aspects. Chest 1989; 96: 499-504... SG Chrysant,C Chrysant,IS Bal,... - 《Chest》 被引量: 39发表: 1989年 treatment of severe hypertension with atenolol and betaxolol with once-daily regimens...
In order to treat hypertensive heart disease, the first step is to treat the high blood pressure that causes it.Hypertensionwill be treated with a variety of drugs, includingdiuretics,beta-blockers,ACE inhibitors (血管张力...
Hypertension affects approximately one third of the world’s adult population and is a major cause of premature death despite considerable advances in pharmacological treatments. Growing evidence supports the use of lifestyle interventions for the prevention and adjuvant treatment of hypertension. In this...
Symptomatic hypotension induced by nifedipine in the acute treatment of severe hypertension. The optimal acute treatment for severe hypertension remains controversial. In the last few years, the use of sublingual and oral nifedipine has been suppor......
High blood pressure (hypertension) - an easy to understand guide covering causes, diagnosis, symptoms, treatment and prevention plus additional in depth medical information.
of patients,adopt corresponding drugs to step-down blood pressure,continue to take drugs when blood pressure is controlled,simultaneously treated the associated complication,patients have received effective treatment.Conclusion Familiar with the principles of hypertension crisis,strengthen emergency rescue and ...
Here we report application of human umbilical cord mesenchymal stem cell (HUCMSC)-derived therapy for pulmonary arterial hypertension (PAH). A 3-year-old female presented with heritable PAH associated with hereditary hemorrhagic telangiectasia and was treated for 6 months with serial intravascular inf...
Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension This has important implications for the pathogenesis and treatment of severe pulmonary hypertension.doi:10.1172/JCI5911Mark W. Geraci... MW Geraci,B Gao,DC Shepherd,... - 《Jour...